Antimicrobial Antifungal Tests Market : TOC


Back to Report

Table of Content

1. Executive Summary

1.1. Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Anti-Microbial/Anti-Fungal Tests Market View Point Analysis 

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Key Regulations

4. North America Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Trends

4.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

4.3.1. U.S.

4.3.2. Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

4.4.1. U.S.

4.4.2. Canada

4.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016

4.5.1. Molecular Based Tests

4.5.1.1. PCR Test

4.5.1.2. DNA Microarray

4.5.2. Phenotypic Resistance Tests

4.5.3. Complex Test Panels

4.5.4. Mass Spectrometry

4.5.5. Rapid Diagnostic Tests

4.5.5.1. E-Test Antibiotic/Antifungal Strips

4.5.5.2. Biosensor Platforms

4.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027

4.6.1. Molecular Based Tests

4.6.1.1. PCR Test

4.6.1.2. DNA Microarray

4.6.2. Phenotypic Resistance Tests

4.6.3. Complex Test Panels

4.6.4. Mass Spectrometry

4.6.5. Rapid Diagnostic Tests

4.6.5.1. E-Test Antibiotic/Antifungal Strips

4.6.5.2. Biosensor Platforms

4.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016

4.7.1. Anti-microbial Resistance

4.7.2. Microbial Infection

4.7.3. Anti-fungal Resistance

4.7.4. Fungal Infection

4.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027

4.8.1. Anti-microbial Resistance

4.8.2. Microbial Infection

4.8.3. Anti-fungal Resistance

4.8.4. Fungal Infection

4.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

4.9.1. Hospitals

4.9.2. Ambulatory Surgical Centers

4.9.3. Clinics

4.9.4. Community Health Centers

4.9.5. Reference Laboratories

4.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

4.10.1.  Hospitals

4.10.2.  Ambulatory Surgical Centers

4.10.3.  Clinics

4.10.4.  Community Health Centers

4.10.5.  Reference Laboratories

4.11. Market Attractiveness Analysis

4.11.1.  By Country

4.11.2.  By Test Type

4.11.3.  By Infection Type 

4.11.4.  By End User

4.12. Intensity Mapping

5. Latin America Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027

5.1. Introduction

5.2. Regional Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.2.3. Trends

5.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

5.3.1. Brazil

5.3.2. Mexico

5.3.3. Rest of Latin America

5.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

5.4.1. Brazil

5.4.2. Mexico

5.4.3. Rest of Latin America

5.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016

5.5.1. Molecular Based Tests

5.5.1.1. PCR Test

5.5.1.2. DNA Microarray

5.5.2. Phenotypic Resistance Tests

5.5.3. Complex Test Panels

5.5.4. Mass Spectrometry

5.5.5. Rapid Diagnostic Tests

5.5.5.1. E-Test Antibiotic/Antifungal Strips

5.5.5.2. Biosensor Platforms

5.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027

5.6.1. Molecular Based Tests

5.6.1.1. PCR Test

5.6.1.2. DNA Microarray

5.6.2. Phenotypic Resistance Tests

5.6.3. Complex Test Panels

5.6.4. Mass Spectrometry

5.6.5. Rapid Diagnostic Tests

5.6.5.1. E-Test Antibiotic/Antifungal Strips

5.6.5.2. Biosensor Platforms

5.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016

5.7.1. Anti-microbial Resistance

5.7.2. Microbial Infection

5.7.3. Anti-fungal Resistance

5.7.4. Fungal Infection

5.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027

5.8.1. Anti-microbial Resistance

5.8.2. Microbial Infection

5.8.3. Anti-fungal Resistance

5.8.4. Fungal Infection

5.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

5.9.1. Hospitals

5.9.2. Ambulatory Surgical Centers

5.9.3. Clinics

5.9.4. Community Health Centers

5.9.5. Reference Laboratories

5.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

5.10.1.  Hospitals

5.10.2.  Ambulatory Surgical Centers

5.10.3.  Clinics

5.10.4.  Community Health Centers

5.10.5.  Reference Laboratories

5.11. Market Attractiveness Analysis

5.11.1.  By Country

5.11.2.  By Test Type

5.11.3.  By Infection Type 

5.11.4.  By End User

5.12. Intensity Mapping

6. Western Europe Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Regional Market Dynamics

6.2.1. Drivers

6.2.2. Restraints

6.2.3. Trends

6.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

6.3.1. Germany

6.3.2. United Kingom

6.3.3. France

6.3.4. Italy

6.3.5. Spain

6.3.6. Nordic Region

6.3.7. Rest of Western Europe

6.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

6.4.1. Germany

6.4.2. United Kingom

6.4.3. France

6.4.4. Italy

6.4.5. Spain

6.4.6. Nordic Region

6.4.7. Rest of Western Europe

6.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016

6.5.1. Molecular Based Tests

6.5.1.1. PCR Test

6.5.1.2. DNA Microarray

6.5.2. Phenotypic Resistance Tests

6.5.3. Complex Test Panels

6.5.4. Mass Spectrometry

6.5.5. Rapid Diagnostic Tests

6.5.5.1. E-Test Antibiotic/Antifungal Strips

6.5.5.2. Biosensor Platforms

6.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027

6.6.1. Molecular Based Tests

6.6.1.1. PCR Test

6.6.1.2. DNA Microarray

6.6.2. Phenotypic Resistance Tests

6.6.3. Complex Test Panels

6.6.4. Mass Spectrometry

6.6.5. Rapid Diagnostic Tests

6.6.5.1. E-Test Antibiotic/Antifungal Strips

6.6.5.2. Biosensor Platforms

6.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016

6.7.1. Anti-microbial Resistance

6.7.2. Microbial Infection

6.7.3. Anti-fungal Resistance

6.7.4. Fungal Infection

6.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027

6.8.1. Anti-microbial Resistance

6.8.2. Microbial Infection

6.8.3. Anti-fungal Resistance

6.8.4. Fungal Infection

6.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

6.9.1. Hospitals

6.9.2. Ambulatory Surgical Centers

6.9.3. Clinics

6.9.4. Community Health Centers

6.9.5. Reference Laboratories

6.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

6.10.1.  Hospitals

6.10.2.  Ambulatory Surgical Centers

6.10.3.  Clinics

6.10.4.  Community Health Centers

6.10.5.  Reference Laboratories

6.11. Market Attractiveness Analysis

6.11.1.  By Country

6.11.2.  By Test Type

6.11.3.  By Infection Type 

6.11.4.  By End User

6.12. Intensity Mapping

7. Eastern Europe Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Regional Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Trends

7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

7.3.1. Russia

7.3.2. Poland

7.3.3. Rest of Eastern Europe

7.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

7.4.1. Russia

7.4.2. Poland

7.4.3. Rest of Eastern Europe

7.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016

7.5.1. Molecular Based Tests

7.5.1.1. PCR Test

7.5.1.2. DNA Microarray

7.5.2. Phenotypic Resistance Tests

7.5.3. Complex Test Panels

7.5.4. Mass Spectrometry

7.5.5. Rapid Diagnostic Tests

7.5.5.1. E-Test Antibiotic/Antifungal Strips

7.5.5.2. Biosensor Platforms

7.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027

7.6.1. Molecular Based Tests

7.6.1.1. PCR Test

7.6.1.2. DNA Microarray

7.6.2. Phenotypic Resistance Tests

7.6.3. Complex Test Panels

7.6.4. Mass Spectrometry

7.6.5. Rapid Diagnostic Tests

7.6.5.1. E-Test Antibiotic/Antifungal Strips

7.6.5.2. Biosensor Platforms

7.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016

7.7.1. Anti-microbial Resistance

7.7.2. Microbial Infection

7.7.3. Anti-fungal Resistance

7.7.4. Fungal Infection

7.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027

7.8.1. Anti-microbial Resistance

7.8.2. Microbial Infection

7.8.3. Anti-fungal Resistance

7.8.4. Fungal Infection

7.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

7.9.1. Hospitals

7.9.2. Ambulatory Surgical Centers

7.9.3. Clinics

7.9.4. Community Health Centers

7.9.5. Reference Laboratories

7.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

7.10.1.  Hospitals

7.10.2.  Ambulatory Surgical Centers

7.10.3.  Clinics

7.10.4.  Community Health Centers

7.10.5.  Reference Laboratories

7.11. Market Attractiveness Analysis

7.11.1.  By Country

7.11.2.  By Test Type

7.11.3.  By Infection Type 

7.11.4.  By End User

7.12. Intensity Mapping

8. Asia Pacific excluding Japan Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Regional Market Dynamics

8.2.1. Drivers

8.2.2. Restraints

8.2.3. Trends

8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

8.3.1. China

8.3.2. India

8.3.3. Australia and New Zealand

8.3.4. ASEAN

8.3.5. Rest of Asia Pacific excluding Japan

8.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

8.4.1. China

8.4.2. India

8.4.3. Australia and New Zealand

8.4.4. ASEAN

8.4.5. Rest of Asia Pacific excluding Japan

8.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016

8.5.1. Molecular Based Tests

8.5.1.1. PCR Test

8.5.1.2. DNA Microarray

8.5.2. Phenotypic Resistance Tests

8.5.3. Complex Test Panels

8.5.4. Mass Spectrometry

8.5.5. Rapid Diagnostic Tests

8.5.5.1. E-Test Antibiotic/Antifungal Strips

8.5.5.2. Biosensor Platforms

8.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027

8.6.1. Molecular Based Tests

8.6.1.1. PCR Test

8.6.1.2. DNA Microarray

8.6.2. Phenotypic Resistance Tests

8.6.3. Complex Test Panels

8.6.4. Mass Spectrometry

8.6.5. Rapid Diagnostic Tests

8.6.5.1. E-Test Antibiotic/Antifungal Strips

8.6.5.2. Biosensor Platforms

8.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016

8.7.1. Anti-microbial Resistance

8.7.2. Microbial Infection

8.7.3. Anti-fungal Resistance

8.7.4. Fungal Infection

8.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027

8.8.1. Anti-microbial Resistance

8.8.2. Microbial Infection

8.8.3. Anti-fungal Resistance

8.8.4. Fungal Infection

8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

8.9.1. Hospitals

8.9.2. Ambulatory Surgical Centers

8.9.3. Clinics

8.9.4. Community Health Centers

8.9.5. Reference Laboratories

8.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

8.10.1.  Hospitals

8.10.2.  Ambulatory Surgical Centers

8.10.3.  Clinics

8.10.4.  Community Health Centers

8.10.5.  Reference Laboratories

8.11. Market Attractiveness Analysis

8.11.1.  By Country

8.11.2.  By Test Type

8.11.3.  By Infection Type 

8.11.4.  By End User

8.12. Intensity Mapping

9. Japan Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Regional Market Dynamics

9.2.1. Drivers

9.2.2. Restraints

9.2.3. Trends

9.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016

9.3.1. Molecular Based Tests

9.3.1.1. PCR Test

9.3.1.2. DNA Microarray

9.3.2. Phenotypic Resistance Tests

9.3.3. Complex Test Panels

9.3.4. Mass Spectrometry

9.3.5. Rapid Diagnostic Tests

9.3.5.1. E-Test Antibiotic/Antifungal Strips

9.3.5.2. Biosensor Platforms

9.4. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027

9.4.1. Molecular Based Tests

9.4.1.1. PCR Test

9.4.1.2. DNA Microarray

9.4.2. Phenotypic Resistance Tests

9.4.3. Complex Test Panels

9.4.4. Mass Spectrometry

9.4.5. Rapid Diagnostic Tests

9.4.5.1. E-Test Antibiotic/Antifungal Strips

9.4.5.2. Biosensor Platforms

9.5. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016

9.5.1. Anti-microbial Resistance

9.5.2. Microbial Infection

9.5.3. Anti-fungal Resistance

9.5.4. Fungal Infection

9.6. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027

9.6.1. Anti-microbial Resistance

9.6.2. Microbial Infection

9.6.3. Anti-fungal Resistance

9.6.4. Fungal Infection

9.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

9.7.1. Hospitals

9.7.2. Ambulatory Surgical Centers

9.7.3. Clinics

9.7.4. Community Health Centers

9.7.5. Reference Laboratories

9.8. Market Size (US$ Mn) Forecast By End User, 2017–2027

9.8.1. Hospitals

9.8.2. Ambulatory Surgical Centers

9.8.3. Clinics

9.8.4. Community Health Centers

9.8.5. Reference Laboratories

9.9. Market Attractiveness Analysis

9.9.1. By Test Type

9.9.2. By Infection Type 

9.9.3. By End User

9.10. Intensity Mapping

10. Middle East & Africa Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027

10.1. Introduction

10.2. Regional Market Dynamics

10.2.1.  Drivers

10.2.2.  Restraints

10.2.3.  Trends

10.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

10.3.1.  GCC Countries

10.3.2.  South Africa

10.3.3.  Rest of Middle East and Africa

10.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

10.4.1.  GCC Countries

10.4.2.  South Africa

10.4.3.  Rest of Middle East and Africa

10.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016

10.5.1.  Molecular Based Tests

10.5.1.1. PCR Test

10.5.1.2. DNA Microarray

10.5.2.  Phenotypic Resistance Tests

10.5.3.  Complex Test Panels

10.5.4.  Mass Spectrometry

10.5.5.  Rapid Diagnostic Tests

10.5.5.1. E-Test Antibiotic/Antifungal Strips

10.5.5.2. Biosensor Platforms

10.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027

10.6.1.  Molecular Based Tests

10.6.1.1. PCR Test

10.6.1.2. DNA Microarray

10.6.2.  Phenotypic Resistance Tests

10.6.3.  Complex Test Panels

10.6.4.  Mass Spectrometry

10.6.5.  Rapid Diagnostic Tests

10.6.5.1. E-Test Antibiotic/Antifungal Strips

10.6.5.2. Biosensor Platforms

10.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016

10.7.1.  Anti-microbial Resistance

10.7.2.  Microbial Infection

10.7.3.  Anti-fungal Resistance

10.7.4.  Fungal Infection

10.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027

10.8.1.  Anti-microbial Resistance

10.8.2.  Microbial Infection

10.8.3.  Anti-fungal Resistance

10.8.4.  Fungal Infection

10.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

10.9.1.  Hospitals

10.9.2.  Ambulatory Surgical Centers

10.9.3.  Clinics

10.9.4.  Community Health Centers

10.9.5.  Reference Laboratories

10.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

10.10.1. Hospitals

10.10.2. Ambulatory Surgical Centers

10.10.3. Clinics

10.10.4. Community Health Centers

10.10.5. Reference Laboratories

10.11. Market Attractiveness Analysis

10.11.1. By Country

10.11.2. By Test Type

10.11.3. By Infection Type 

10.11.4. By End User

10.12. Intensity Mapping

11. Forecast Factors: Relevance and Impact

12. Competition Landscape

12.1. Market Structure

12.2. Competition Dashboard

12.3. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)

12.3.1.  Abbott Laboratories 

12.3.2.  bioMérieux SA 

12.3.3.  Bio-Rad Laboratories Inc. 

12.3.4.  Bruker Corporation 

12.3.5.  Danaher Corporation

12.3.6.  Erba Mannheim

12.3.7.  F. Hoffmann-La Roche AG 

12.3.8.  Luminex Corporation 

12.3.9.  Meridian Bioscience Inc. 

12.3.10. Norgen Biotek Corp. 

12.3.11. Omega Diagnostics Group Plc. 

12.3.12. Qiagen N.V. 

12.3.13. Quidel Corporation

12.3.14. Thermo Fisher Scientific Inc.

13. Global Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027, By Region

13.1. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016

13.1.1.  North America

13.1.2.  Latin America

13.1.3.  Western Europe

13.1.4.  Eastern Europe

13.1.5.  Asia Pacific excluding Japan

13.1.6.  Japan

13.1.7.  Middle East & Africa

13.2. Market Size (US$ Mn) Forecast By Region, 2017–2027

13.2.1.  North America

13.2.2.  Latin America

13.2.3.  Western Europe

13.2.4.  Eastern Europe

13.2.5.  Asia Pacific excluding Japan

13.2.6.  Japan

13.2.7.  Middle East & Africa

13.3. Market Attractiveness Analysis By Region

14. Global Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027, By Test Type 

14.1. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016

14.1.1.  Molecular Based Tests

14.1.1.1. PCR Test

14.1.1.2. DNA Microarray

14.1.2.  Phenotypic Resistance Tests

14.1.3.  Complex Test Panels

14.1.4.  Mass Spectrometry

14.1.5.  Rapid Diagnostic Tests

14.1.5.1. E-Test Antibiotic/Antifungal Strips

14.1.5.2. Biosensor Platforms

14.2. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027

14.2.1.  Molecular Based Tests

14.2.1.1. PCR Test

14.2.1.2. DNA Microarray

14.2.2.  Phenotypic Resistance Tests

14.2.3.  Complex Test Panels

14.2.4.  Mass Spectrometry

14.2.5.  Rapid Diagnostic Tests

14.2.5.1. E-Test Antibiotic/Antifungal Strips

14.2.5.2. Biosensor Platforms

14.3. Market Attractiveness Analysis By Test Type

15. Global Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2015 and Forecast 2017–2027, By Infection Type

15.1. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016

15.1.1.  Anti-microbial Resistance

15.1.2.  Microbial Infection

15.1.3.  Anti-fungal Resistance

15.1.4.  Fungal Infection

15.2. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027

15.2.1.  Anti-microbial Resistance

15.2.2.  Microbial Infection

15.2.3.  Anti-fungal Resistance

15.2.4.  Fungal Infection

15.3. Market Attractiveness Analysis By Infection Type

16. Global Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027, By End User

16.1. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

16.1.1. Hospitals

16.1.2. Ambulatory Surgical Centers

16.1.3. Clinics

16.1.4. Community Health Centers

16.1.5. Reference Laboratories

16.2. Market Size (US$ Mn) Forecast By End User, 2017–2027

16.2.1. Hospitals

16.2.2. Ambulatory Surgical Centers

16.2.3. Clinics

16.2.4. Community Health Centers

16.2.5. Reference Laboratories

16.3.Market Attractiveness Analysis By End User

17. Assumptions and Acronyms Used

18. Research Methodology

Request Methodology of This Report

Request Methodology

First Time Buyer ?

Check Discount

Request a Sample

Click button below to request a sample of this report

Request Sample

About This Report


  • Rep Id : XPLREP947
  • Publised On : November, 2017
  • No. of Pages : 268
  • Category : Medical Equipments
  • Publisher : Future Market Insights